120 reports of this reaction
2.2% of all BENZTROPINE MESYLATE reports
#4 most reported adverse reaction
DEATH is the #4 most commonly reported adverse reaction for BENZTROPINE MESYLATE, manufactured by Chartwell RX, LLC.. There are 120 FDA adverse event reports linking BENZTROPINE MESYLATE to DEATH. This represents approximately 2.2% of all 5,542 adverse event reports for this drug.
Patients taking BENZTROPINE MESYLATE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a less commonly reported adverse event for BENZTROPINE MESYLATE, but still significant enough to appear in the safety profile.
In addition to death, the following adverse reactions have been reported for BENZTROPINE MESYLATE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 120 FDA reports for BENZTROPINE MESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 2.2% of all adverse event reports for BENZTROPINE MESYLATE, making it a notable side effect.
If you experience death while taking BENZTROPINE MESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.